Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.16 USD | +0.42% | +7.67% | +6.87% |
20/05 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
17/05 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 2.69B | |
+31.13% | 456B | |
+33.63% | 280B | |
+3.90% | 134B | |
+30.50% | 94.31B | |
+62.27% | 60.48B | |
+14.09% | 46.13B | |
+25.91% | 37.31B | |
-0.62% | 35.48B | |
+12.07% | 28.36B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Morgan Stanley Adjusts Price Target on GoodRx to $5.50 From $8, Maintains Equalweight Rating